OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Lian Narunsky-Haziza, Gregory D. Sepich‐Poore, Ilana Livyatan, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3789-3806.e17
Open Access | Times Cited: 289
Lian Narunsky-Haziza, Gregory D. Sepich‐Poore, Ilana Livyatan, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3789-3806.e17
Open Access | Times Cited: 289
Showing 1-25 of 289 citing articles:
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy
Yang Li, Aitian Li, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 169
Yang Li, Aitian Li, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 169
Immune responses to human fungal pathogens and therapeutic prospects
Michail S. Lionakis, Rebecca A. Drummond, Tobias M. Hohl
Nature reviews. Immunology (2023) Vol. 23, Iss. 7, pp. 433-452
Open Access | Times Cited: 150
Michail S. Lionakis, Rebecca A. Drummond, Tobias M. Hohl
Nature reviews. Immunology (2023) Vol. 23, Iss. 7, pp. 433-452
Open Access | Times Cited: 150
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 130
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 130
Embracing cancer complexity: Hallmarks of systemic disease
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 103
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 103
Cryptococcus neoformans, a global threat to human health
Youbao Zhao, Leixin Ye, Fujie Zhao, et al.
Infectious Diseases of Poverty (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 83
Youbao Zhao, Leixin Ye, Fujie Zhao, et al.
Infectious Diseases of Poverty (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 83
Lung microbiome: new insights into the pathogenesis of respiratory diseases
Ruomeng Li, Jing Li, Xikun Zhou
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80
Ruomeng Li, Jing Li, Xikun Zhou
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80
Targeting ROS in cancer: rationale and strategies
Christophe Glorieux, Shihua Liu, Dunyaporn Trachootham, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 583-606
Closed Access | Times Cited: 77
Christophe Glorieux, Shihua Liu, Dunyaporn Trachootham, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 583-606
Closed Access | Times Cited: 77
The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells
Ning‐Ning Liu, Cheng-Xiang Yi, Luqi Wei, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1927-1944.e9
Open Access | Times Cited: 68
Ning‐Ning Liu, Cheng-Xiang Yi, Luqi Wei, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1927-1944.e9
Open Access | Times Cited: 68
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 61
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 61
The landscape of T cell antigens for cancer immunotherapy
Aviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Nature Cancer (2023) Vol. 4, Iss. 7, pp. 937-954
Closed Access | Times Cited: 53
Aviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Nature Cancer (2023) Vol. 4, Iss. 7, pp. 937-954
Closed Access | Times Cited: 53
The global human gut microbiome: genes, lifestyles, and diet
Mona Parizadeh, Marie‐Claire Arrieta
Trends in Molecular Medicine (2023) Vol. 29, Iss. 10, pp. 789-801
Closed Access | Times Cited: 50
Mona Parizadeh, Marie‐Claire Arrieta
Trends in Molecular Medicine (2023) Vol. 29, Iss. 10, pp. 789-801
Closed Access | Times Cited: 50
Intratumoural microbiota: a new frontier in cancer development and therapy
Yaqi Cao, Hui Xia, Xueyun Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44
Yaqi Cao, Hui Xia, Xueyun Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44
Utilization of the microbiome in personalized medicine
Karina Ratiner, Dragos Ciocan, Suhaib K. Abdeen, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 5, pp. 291-308
Closed Access | Times Cited: 42
Karina Ratiner, Dragos Ciocan, Suhaib K. Abdeen, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 5, pp. 291-308
Closed Access | Times Cited: 42
Chemiluminescent probes in cancer biology
Rachel Blau, Omri Shelef, Doron Shabat, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 9, pp. 648-664
Closed Access | Times Cited: 41
Rachel Blau, Omri Shelef, Doron Shabat, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 9, pp. 648-664
Closed Access | Times Cited: 41
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 31
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 31
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Bin Song, Ping Yang, Shuyu Zhang
Cancer Communications (2024) Vol. 44, Iss. 3, pp. 297-360
Open Access | Times Cited: 20
Bin Song, Ping Yang, Shuyu Zhang
Cancer Communications (2024) Vol. 44, Iss. 3, pp. 297-360
Open Access | Times Cited: 20
Broadening oncological boundaries: the intratumoral microbiota
Ying‐Qi Lu, Han Qiao, Xi-Rong Tan, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 807-822
Open Access | Times Cited: 15
Ying‐Qi Lu, Han Qiao, Xi-Rong Tan, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 807-822
Open Access | Times Cited: 15
Roles of microbiota in pancreatic cancer development and treatment
Mariana Santos Cruz, Joseph Tintelnot, Nicola Gagliani
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 14
Mariana Santos Cruz, Joseph Tintelnot, Nicola Gagliani
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 14
Robustness of cancer microbiome signals over a broad range of methodological variation
Gregory D. Sepich‐Poore, Daniel McDonald, Evguenia Kopylova, et al.
Oncogene (2024) Vol. 43, Iss. 15, pp. 1127-1148
Open Access | Times Cited: 13
Gregory D. Sepich‐Poore, Daniel McDonald, Evguenia Kopylova, et al.
Oncogene (2024) Vol. 43, Iss. 15, pp. 1127-1148
Open Access | Times Cited: 13
Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 35
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 35
Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts
Xiaowen Huang, Muni Hu, Tiantian Sun, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 11, pp. 1930-1943.e4
Open Access | Times Cited: 31
Xiaowen Huang, Muni Hu, Tiantian Sun, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 11, pp. 1930-1943.e4
Open Access | Times Cited: 31
The human microbiome and cancer: a diagnostic and therapeutic perspective
Shruthi Kandalai, Huapeng Li, Nan Zhang, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 29
Shruthi Kandalai, Huapeng Li, Nan Zhang, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 29
Intracellular bacteria in cancer—prospects and debates
Lena Schorr, Marius Mathies, Eran Elinav, et al.
npj Biofilms and Microbiomes (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 28
Lena Schorr, Marius Mathies, Eran Elinav, et al.
npj Biofilms and Microbiomes (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 28
Fungi and cancer
Aurelia Saftien, Jens Puschhof, Eran Elinav
Gut (2023) Vol. 72, Iss. 7, pp. 1410-1425
Open Access | Times Cited: 25
Aurelia Saftien, Jens Puschhof, Eran Elinav
Gut (2023) Vol. 72, Iss. 7, pp. 1410-1425
Open Access | Times Cited: 25
Mediterranean diet and olive oil, microbiota, and obesity-related cancers. From mechanisms to prevention
Enrique Almanza‐Aguilera, Ainara Cano, Mercedes Gil‐Lespinard, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 103-119
Open Access | Times Cited: 24
Enrique Almanza‐Aguilera, Ainara Cano, Mercedes Gil‐Lespinard, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 103-119
Open Access | Times Cited: 24
